Funding for this research was provided by:
Fundo de Apoio À Pesquisa - Sociedade Brasileira de Reumatologia (-)
Received: 5 June 2019
Accepted: 26 December 2019
First Online: 6 January 2020
Ethics approval and consent to participate
: This work was approved by Faculdade de Medicina da Universidade de São Paulo Ethics Review Board under number 1.464.841 on March 24th 2016. All patients read and signed informed consent. The procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation and with the Helsinki Declaration of 1975, as revised in 1983.
: Not applicable.
: NSRN declares having received speaker’s and advisory board fees from Shire HGT, now Takeda Pharmaceuticals; JCBB declares that spouse received speaker’s and advisory board fees from Shire HGT, now Takeda Pharmaceuticals; RMRP has nothing to disclose.